New flu pill passes first safety hurdle in small human study
NCT ID NCT05202379
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested a new oral drug called CC-42344 in 80 healthy adults to see if it is safe and how the body processes it. The drug is designed to stop the influenza A virus from multiplying. The study did not treat actual flu patients, but the results will help decide whether to test it further in people with the flu.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CC-42344 (an oral capsule that aims to stop the flu virus from multiplying)
What this could lead to
If safe and effective in later trials, this drug could become a new treatment option for influenza A, helping reduce symptoms and shorten illness.
What could go wrong
This is a very early Phase 1 study focused on safety and dosing in healthy people, not on treating flu. Many drugs fail in later stages, and it may not prove effective against the virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia